|
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 Clinical research trials and Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1. Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 clinical trial. Participants typically obtain the most effective healthcare available for their Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1 condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1  Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1
For Condition: Cocaine-Related Disorders,Substance-Related Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) , University of California, Los Angeles
Synopsis: A Phase 2, Double-Blind, Placebo-Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Details: To assess the efficacy and safety of cabergoline in reducing cocaine use in subjects with cocaine dependence. This is a DB, placebo-controlled, parallel group design study where subjects will receive either .5mg cabergoline or placebo for 12 weeks with a 4 week follow-up.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Must be at least 18 yrs of age; have a DSM-4 criteria for cocaine dependence; be seeking treatment for cocaine dependence; have the ability to understand and provide written informed consent; females of child-bearing potential using proper method of birth control. Exclusion Criteria: Additional criteria available during screening at the site.
Total Enrollment: 140
Location and Contact Information:
Overall Study Official:
SteveShoptaw, Principal Investigator, Friends Research Institute
Medical University of South Carolina
Charleston, South Carolina, 29425
United States
Torrance Clinic
Torrance, California, 90502
United States
Additional Information:
Study ID Numbers: NIDA-CTO-0007-1;
Study Start Date: June 2001
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033111
Other Substance-Related Disorders Studies:
1. Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study with Three Dosages of GBR 12909 in Cocaine Experienced Volunteers - 1
2. Pergolide Treatment for Substance Abusers - 4
3. Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
4. Infusion Laboratory: Protocol 3 (Risperidone) - 4
5. Cocaine-Methylphendidate Interaction Study - 4
Related Studies:
Other Substance-Related Disorders Clinical Trials
Other California Clinical Trials
Other Torrance Clinical Trials
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1
|
|
|
|
|
|
|
|
